Skip to search boxSkip to navigationSkip to main content

MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity

  • Kimberly R. Cordes
    ,
  • Neil T. Sheehy
    ,
  • Mark P. White
    ,
  • Emily C. Berry
    ,
  • Sarah U. Morton
    ,
  • Alecia N. Muth
*Corresponding author for this work
  • University of California at San Francisco
    ,
  • Gladstone Institutes
    ,
  • University of Rochester
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

MicroRNAs (miRNAs) are regulators of myriad cellular events, but evidence for a single miRNA that can efficiently differentiate multipotent stem cells into a specific lineage or regulate direct reprogramming of cells into an alternative cell fate has been elusive. Here we show that miR-145 and miR-143 are co-transcribed in multipotent murine cardiac progenitors before becoming localized to smooth muscle cells, including neural crest stem-cell-derived vascular smooth muscle cells. miR-145 and miR-143 were direct transcriptional targets of serum response factor, myocardin and Nkx2-5 (NK2 transcription factor related, locus 5) and were downregulated in injured or atherosclerotic vessels containing proliferating, less differentiated smooth muscle cells. miR-145 was necessary for myocardin-induced reprogramming of adult fibroblasts into smooth muscle cells and sufficient to induce differentiation of multipotent neural crest stem cells into vascular smooth muscle. Furthermore, miR-145 and miR-143 cooperatively targeted a network of transcription factors, including Klf4 (Kruppel-like factor 4), myocardin and Elk-1 (ELK1, member of ETS oncogene family), to promote differentiation and repress proliferation of smooth muscle cells. These findings demonstrate that miR-145 can direct the smooth muscle fate and that miR-145 and miR-143 function to regulate the quiescent versus proliferative phenotype of smooth muscle cells.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 705-710 (6 pages)

Journal (Volume, Issue Number)

Nature (Volume 460, Issue 7256)

Publication milestones

  • Published - 08/06/2009

Publication status

Published - 08/06/2009

ISSN

0028-0836

Publication IDs

  • Scopus: 68449097267
  • PubMed: 19578358

Publication metrics

Metrics

Fractional count
1
Fractional count
0.10
Fractional count
9
Fractional count
0.90
Fractional count
1
Fractional count
1
SciVal
citations
1143
SciVal
FWCI
13.89
SciVal
Author count
10
SciVal
Paper percentile
99
SciVal
Top percentile
1
Scopus
citations

PlumX, opens in new tab

Mentions
3
Captures
754
Citation count
1498
Social media
6

Funding Details

Acknowledgements We thank R. Blelloch for DGCR8-null EBs; R.J. Schwartz for SRF-null ES cells; I. Charo and N. Saederup for RNA from atherosclerotic tissue; J. Maurer for JoMa neural crest cell line; L. Qian and Y. Huang for providing mouse cardiac infarct RNA; C. Tsou for help with calcium flux assays; E. N. Olson for the myocardin expression plasmid; P. Swinton for generation of transgenic mice; J. Fish and C. Miller for histopathology support; S. Ordway and G. Howard for scientific editing; B. Taylor for manuscript preparation. We also thank members of the Srivastava laboratory for discussions. J.M.M. was supported by HL62572 and HL091168 from NHLBI/NIH. D.S. was supported by grants from the NHLBI/NIH and the California Institute for Regenerative Medicine (CIRM) and was an Established Investigator of the American Heart Association. This work was also supported by NIH/NCRR grant C06 RR018928 to the Gladstone Institutes.
FundersFunding numbers
NHLBI/NIH
-
NIH/NCRR
C06 RR018928
NHLBI
R01HL062572
CIRM
-
AHA
-